Where pharma's R&D dollars will flow in 2024

Oncology will continue to be the main research and development focus of the pharmaceutical industry in 2024, according to a new report from Evaluate Pharma.

Evaluate Pharma offers clients forecasts of the pharmaceutical industry in its annual World Preview.

The top R&D focus areas and forecasted dollar amount:

1. Oncology ($91.1 billion)
2. Central nervous system ($31 billion)
3. Musculoskeletal ($19.9 billion)
4. Cardiovascular ($19.7 billion)
5. Immunomodulators ($15 billion)
6. Respiratory ($9.2 billion)
7. Gastro-Intestinal ($8.4 billion)
8. Systemic Anti-infectives ($8.2 billion)
9. Blood ($6.4 billion)
10. Sensory organs ( $4.9 billion)
11. Dermatology ($3.9 billion)
12. Endocrine ($3.9 billion)
13. Genito-Urinary ($2 billion)
14. Other ($4.1 billion)

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars